NASDAQ · Analyst Forecast

MacroGenics, Inc. (MGNX) Analyst Forecast

$2.05 NASDAQ: MGNX Market Cap $130.27M

Revenue and earnings estimates published by analysts covering MacroGenics, Inc. (MGNX), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For MacroGenics, Inc., analysts forecast revenue falling from $138.85T in 2025 to $128.04T in 2030; the average estimate for 2030 earnings per share is $-1.01; with published estimates ranging from $-1.51 to $-0.52; 5 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

Measure	Value
Current priceWhat the share trades at now.	$2.05
Consensus targetThe average of the price targets analysts have published.	$9.78
Median targetThe middle target, less affected by a single outlier.	$8.00
Highest targetThe most optimistic published target.	$32.00
Lowest targetThe most pessimistic published target.	$2.00
Difference from priceHow far the consensus target sits from today’s price.	+377.1%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD millions)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

Year	Low	Average	High	Analysts
2025	$69.05T	$138.85T	$189.05T	3
2026	$103.79T	$109.83T	$115.88T	5
2027	$70.14T	$90.61T	$111.07T	4
2028	$58.70T	$88.17T	$124.45T	4
2029	$56.45T	$89.96T	$123.80T	2
2030	$80.34T	$128.04T	$176.19T	2

Earnings per share forecast

Year	Low	Average	High	Analysts
2025	$-1.77	$-1.09	$-0.69	3
2026	$-2.62	$-1.76	$-0.91	5
2027	$-2.23	$-1.64	$-1.05	4
2028	$-3.35	$-2.05	$-1.43	4
2029	$-3.04	$-2.04	$-1.05	2
2030	$-1.51	$-1.01	$-0.52	2

MacroGenics, Inc. (MGNX) forecast — frequently asked questions

What is the analyst price target for MacroGenics, Inc.?

Analysts covering MacroGenics, Inc. (MGNX) have a consensus price target of $9.78, 377.1% above the current price of $2.05. Published targets range from $2.00 to $32.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for MacroGenics, Inc.'s earnings?

The average analyst estimate for MacroGenics, Inc. (MGNX) earnings per share in 2030 is -1.01, with individual estimates between -1.51 and -0.52.

How much revenue is MacroGenics, Inc. expected to make?

Analysts forecast MacroGenics, Inc. (MGNX) revenue of $128.04T in 2030, based on 2 published estimates.

How many analysts cover MGNX?

5 analysts contribute estimates for MacroGenics, Inc. (MGNX). Thin coverage makes an average less reliable.

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks Nasdaq High ROE Stocks All stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.